Martijn Cox
Gründer bei Xeltis AG
Aktive Positionen von Martijn Cox
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 | - |
Gründer | 01.01.2006 | - | |
Xeltis BV
Xeltis BV Packaged SoftwareTechnology Services Xeltis BV develops self-growing heart valves out of patients tissue. The company was headquartered in Glasgow, the United Kingdom. The company was founded on November 20, 2007 by Mirjam Rubbens and Martijn Cox and is headquartered in Eindhoven, the Netherlands. | Gründer | 20.11.2007 | - |
Karriereverlauf von Martijn Cox
Ausbildung von Martijn Cox
TiasNimbas Business School BV | Doctorate Degree |
Statistik
International
Niederlande | 3 |
Schweiz | 2 |
Operativ
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sektoral
Consumer Services | 2 |
Health Technology | 2 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Health Technology |
Xeltis BV
Xeltis BV Packaged SoftwareTechnology Services Xeltis BV develops self-growing heart valves out of patients tissue. The company was headquartered in Glasgow, the United Kingdom. The company was founded on November 20, 2007 by Mirjam Rubbens and Martijn Cox and is headquartered in Eindhoven, the Netherlands. | Technology Services |
- Börse
- Insiders
- Martijn Cox
- Erfahrung